Dr Julio Ortiz Mcwilliam, MD in Humacao, PR - Medicare Otolaryngology

Dr Julio Ortiz Mcwilliam, MD is a medicare enrolled "Otolaryngology" physician in Humacao, Puerto Rico. He went to Georgetown University School Of Medicine and graduated in 1982 and has 42 years of diverse experience with area of expertise as Otolaryngology. His current practice location is 5 Calle Dufresne E, Humacao, Puerto Rico. You can reach out to his office (for appointments etc.) via phone at (787) 656-5247.

Dr Julio Ortiz Mcwilliam is licensed to practice in Puerto Rico (license number 9187) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1336219880.

Contact Information

	Dr Julio Ortiz Mcwilliam, MD
	5 Calle Dufresne E, Humacao, PR 00791-3605
	(787) 656-5247
	Not Available

Physician's Profile

Full Name	Dr Julio Ortiz Mcwilliam
Gender	Male
Speciality	Otolaryngology
Experience	42 Years
Location	5 Calle Dufresne E, Humacao, Puerto Rico
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Julio Ortiz Mcwilliam attended and graduated from Georgetown University School Of Medicine in 1982

NPI Data:

NPI Number: 1336219880
Provider Enumeration Date: 11/09/2006
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 0446267587
Enrollment ID: I20080529000871

Medical Identifiers

Medical identifiers for Dr Julio Ortiz Mcwilliam such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1336219880	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	9187 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Julio Ortiz Mcwilliam is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Julio Ortiz Mcwilliam, MD 5 Calle Dufresne E, Humacao, PR 00791-3605 Ph: (787) 656-5247	Dr Julio Ortiz Mcwilliam, MD 5 Calle Dufresne E, Humacao, PR 00791-3605 Ph: (787) 656-5247

News Archive

Standard & Poor's upgrades HTA's investment grade credit rating to BBB

Healthcare Trust of America, Inc. (NYSE: HTA) announced today that Standard & Poor's ("S&P") has upgraded HTA's investment grade credit rating to BBB, with a stable outlook.

BTI's IPOXYN data on traumatic shock and ischemia to be presented at XIIIth MGH symposium

Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, announced today that experiments performed in the laboratory of Massachusetts General Hospital (MGH) faculty member Warren M. Zapol, MD, Emeritus Anesthetist-in-Chief and Director of the MGH Anesthesia Center for Critical Care Research, on BTI's new oxygen carrier for traumatic shock and ischemia, IPOXYNTM, will be presented at the "XIII International Symposium on Blood Substitutes and Oxygen Therapeutics" to be held July 27th-29th at MGH.

Atrium completes enrollment in iCAST Atrium Registry Ultrasound Study

Atrium Medical Corporation is pleased to announce that the final patient was recently enrolled in the iCAST™ Atrium Registry Ultrasound Study (iCARUS). This study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST™ Balloon Expandable Covered Stent in patients with occlusive disease of the iliac artery.

Age of psoriasis onset decides if the skin or joints act up first

People with psoriatic arthritis may initially present with either psoriasis or arthritis as the first symptom/sign of this illness. Now, a new study presented at the 2019 ACR/ARP Annual Meeting shows that the age at which psoriasis develops is a key predictor of which shows up first. Early-onset psoriasis is not strongly associated with arthritis while late-onset psoriasis is.

Dr Julio Ortiz Mcwilliam, MD - Medicare Otolaryngology in Humacao, PR